Print
Email
Bookmark
RSS
New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer
Researchers have developed
synthetic molecules capable
of enhancing the body's
immune response to HIV and
HIV-infected cells, as well
... > full story
Key To How 'Triggering Event' In Cancer Occurs: Researchers Link Hormone To Creation Of Gene Fusion In Prostate Cancer
Researchers have discovered
what leads to two genes
fusing together, a
phenomenon that has been
shown to cause prostate
... > full story
Delivery Of Cancer-Fighting Molecules Improved
Researchers have modified
siRNA, a type of genetic
material that can block
potentially harmful activity
in cells, so that it can be
injected into the
... > full story
First Evidence Of Virus In Malignant Prostate Cells: XMRV Retrovirus Linked To More Aggressive Tumors
In a finding with
potentially major
implications for identifying
a viral cause of prostate
cancer, researchers have
... > full story
- New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer
- Key To How 'Triggering Event' In Cancer Occurs: Researchers Link Hormone To Creation Of Gene Fusion In Prostate Cancer
- Delivery Of Cancer-Fighting Molecules Improved
- First Evidence Of Virus In Malignant Prostate Cells: XMRV Retrovirus Linked To More Aggressive Tumors
Browse News Stories
1 to 10 of 773 stories (170 over past year)
view headlines only
-
Routine Evaluation of Prostate Size Not as Effective in Cancer Screening, Study Finds
November 14, 2009 — New research studied the association between prostate-specific antigen levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the ... > full story -
Chemo-Radiation Before Prostate Removal May Prevent Cancer Recurrence
November 11, 2009 — Researchers have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient ... > full story -
Shorter Radiation Course Stops Cancer Growth In High-Risk Prostate Cancer Patients
November 10, 2009 — Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more ... > full story -
Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer
November 9, 2009 — Men whose prostate specific antigen rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international ... > full story -
Low Cholesterol May Shrink Risk For High-Grade Prostate Cancer
November 6, 2009 — Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer -- an aggressive form of the disease with a poorer prognosis, according to results of a ... > full story -
Prostate Biopsy Is Not Always Necessary, New Finding Suggests
November 6, 2009 — Researchers have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need ... > full story -
Does Race, Income Predict Prostate Cancer Outcome? No, New Study Suggests
November 5, 2009 — A patient's socioeconomic status (income, martial status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a ... > full story -
Does Prostate-Specific Antigen Velocity Help In Early Detection Prostate Cancer?
November 5, 2009 — A new article focuses on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer ... > full story -
Blood Vessels Might Predict Prostate Cancer Behavior
November 4, 2009 — A study of 572 men with localized prostate cancer suggests that size and shape of tumor blood vessels may predict whether the tumor will grow aggressively and require immediate treatment or grow ... > full story -
Shorter Radiation Course As Effective As Standard Therapy For Prostate Cancer Recurrence
November 3, 2009 — A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the ... > full story
Search ScienceDaily
Number of stories in archives: 78,023
